Bentham Science Logo
Track your manuscript:


Scopus CiteScore Metrics: 1.37

Browse Contents
Select Volume:  

Select Issue:  

Select Article:


Abstracted/Indexed in




Endorsements

"Current Pharmaceutical Biotechnology presents the latest developments in the area of biotechnology. This is strongly recommended."

Robert Huber
Nobel Laureate

Forthcoming Special Issues

LIPOSOMES AND IMMUNOLIPOSOMES AS NANOCARRIERS FOR DIAGNOSIS AND THERAPY


Guest Editor(s): Mourad Aribi, Hab
Tentative Publication Date: January, 2019
Submit Abstract via Email Download Description
Special Issues - In-Press
Please visit again after some time to view these Issues.
Published Special Issues

Molecular, cellular and pharmaceutical aspects of autologous grafts for perimplant hard and soft tissue defects


Current Pharmaceutical Biotechnology, Volume 18, Number 1
Guest Editor(s): Cieslik Bielecka

Authors' Comments
No doubt we had a great experience with Bentham Science Publishers as the article processing time is less as compared to many other reputed journals.

Nupur Jauhari
(Department of Biotechnology, Nupur Jauhari, Navneeta Bharadvaja, Delhi Technological University, Delhi, India)


Current Pharmaceutical Biotechnology

,

Volume 19

-

Number 13



Biography   Open Access



Editorial   Open Access



Review Article

Cinnamate Hybrids: A Unique Family of Compounds with Multiple Biological Activities

, 19(13): 1019 - 1048

Eleni Pontiki*, Aikaterini Peperidou, Ioannis Fotopoulos and Dimitra Hadjipavlou-Litina*


DOI: 10.2174/1389201019666181112102702




Review Article



Research Article



Research Article



Research Article



Current Pharmaceutical Biotechnology, Volume 19 (2018) - Number 14


This issue is in progress but contains articles that are final and fully citable.

Articles Ahead of Print

The Capability to Forecast Response to Therapy with Regard to The Time and Intensity of The Inflammatory Process in vitro in Dermal Fibroblasts Induced by IL-12


Beniamin Grabarek, Dominika Wcisło – Dziadecka*, Barbara Strzałka – Mrozik, Jolanta Adamska, Urszula Mazurek and Ligia Brzezińska – Wcisło


View Abstract


Molecular Identification and Antimicrobial Activity of Vaginal Lactobacillus sp


Mujde Eryilmaz*, Suna Sibel Gurpinar, Ismail Murat Palabiyik, Haluk Guriz and Devran Gerceker


View Abstract





The Role of Extracellular Nucleic Acids in Rheumatoid Arthritis


Elena Neumann*, Rebecca Hasseli, Uwe Lange and Ulf Müller-Ladner


View Abstract View on PubMed


Hyperglycemia and Diabetes Induced by Glucocorticoids in Nondiabetic and Diabetic Patients: Revision of Literature and Personal Considerations


Ceccarelli Elena*, Mattaliano Chiara, Brazzi Angelica, Marinetti Adriana Chiara, Nigi Laura, Chirico Chiara, Corallo Claudio, Fioravanti Antonella and Giordano Nicola


View Abstract View on PubMed



Optimization of Silver Nanoparticle Synthesis by Banana Peel Extract Using Statistical Experimental Design, and Testing of their Antibacterial and Antioxidant Properties


Nickolas Rigopoulos*, Eleni Thomou, Αntonios Kouloumpis, Eleni Rafaela Lamprou, Varvara Petropoulea, Dimitrios Gournis, Efthymios Poulios, Haralampos C. Karantonis and Efstathios Giaouris


View Abstract


Food with Influence in the Sexual and Reproductive Health


Tania Silva, Mariana Jesus, Cesar Cagigal and Carla Silva*


View Abstract View on PubMed


Abstracts Ahead of Print

There are currently no Abstracts Ahead of Print available for this journal.

Drs. Eric Betzig, Stefan W. Hell and William E. Moerner share the 2014 chemistry Nobel for the development of super-resolved fluorescence microscopy.

“The Royal Swedish Academy of Sciences has decided to award the 2014 Nobel Prize in Chemistry to Dr. Eric Betzig at Howard Hughes Medical Institute, Ashburn, U.S.A.; Professor Stefan Hell at Max Planck Institute for Biophysical Chemistry, Göttingen, and the German Cancer Research Center, Heidelberg, Germany; and Professor William Moerner at Stanford University, Stanford, U.S.A., for the development of super-resolved fluorescence microscopy.”

Much research effort was needed to realize that single-cell and single-molecule based approaches directly affect improvements in human health. However, many of these laboratory technologies are not available in a cheap and easy version. Single-molecule based fluorescence imaging and detection have the advantages of a small volume platform, digital analysis, elimination of processing steps, real-time measurements and automation of sample preparation. In 2015, Current Pharmaceutical Biotechnology will continue in this direction with quality papers that can be expected to trigger further investigations.

Drs. Eric Betzig and William E. Moerner also developed methods and biotechniques which have enabled the study of single molecules in ongoing chemical reactions in living cells. Because now it is possible to see individual macromolecules moving about in a living cell, we can study chemistry at a single-molecule level and in real life. And this is very important to chemistry because chemistry has traditionally been about studying a large number of molecules and the effect that they have. The journal Current Pharmaceutical Biotechnology has published on this research and has been at the forefront for over more than one decade. Curr. Pharm. Biotechnol. has published thematic issues, original research and review articles about the entirely new possibilities for chemistry and for biochemistry by eminent scientists from around the world, some examples:

Editor's Choice




Factors Regulating Human Extravillous Trophoblast Invasion: Chemokine-peptidase and CD9-integrin Systems

, 2018; 19(10): 764 - 770

Hiroshi Fujiwara*, Hisanori Matsumoto, Yukiyasu Sato, Akihito Horie, Masanori Ono, Mitsuhiro Nakamura, Yasunari Mizumoto, Kyosuke Kagami, Tomoko Fujiwara, Akira Hattori, Yoshiko Maida, Takiko Daikoku, Kazuhiko Imakawa and Yoshihiko Araki


DOI: 10.2174/1389201019666181029164906







Perspectives of Nanoemulsion Strategies in The Improvement of Oral, Parenteral and Transdermal Chemotherapy

, 2018; 19(4): 276 - 292

Manisha Pandey*, Hira Choudhury, Ong C. Yeun, Hoh M. Yin, Tan W. Lynn, Celine L.Y. Tine, Ng S. Wi, Kelly C.C. Yen, Cheng S. Phing, Prashant Kesharwani, Subrat K. Bhattamisra and Bapi Gorain*


DOI: 10.2174/1389201019666180605125234



Establishment of Novel Reporter Cells Stably Maintaining Transcription Factor-driven Human Secreted Alkaline Phosphatase Expression

, 2018; 19(3): 224 - 231

Riho Kurata, Asuka Kumagai, Xiaofeng Cui, Masamitsu Harada, Jun Nagai, Yasuhiro Yoshida, Kei-ichi Ozaki, Yoshimasa Tanaka and Tomo Yonezawa*


DOI: 10.2174/1389201019666180418093334



Open Access Articles

Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma

, 2018; 19(8): 611 - 621

Ryan L. Setten, Helen L. Lightfoot, Nagy A. Habib and John J. Rossi*





Verification between Original and Biosimilar Therapeutic Antibody Infliximab Using nSMOL Coupled LC-MS Bioanalysis in Human Serum

, 2018; 19(6): 495 - 505

Noriko Iwamoto, Kotoko Yokoyama, Megumi Takanashi, Atsushi Yonezawa, Kazuo Matsubara and Takashi Shimada*





Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances

, 2018; 19(2): 91 - 98

Claude Guillou*, Fabiano Reniero, Joana Lobo Vicente, Margaret Holland, Kamil Kolar, Hubert Chassaigne, Salvatore Tirendi and Herve Schepers






New Developments in CRISPR Technology: Improvements in Specificity and Efficiency

, 2017; 18(13): 1038 - 1054

Fatemeh Safari, Safar Farajnia*, Younes Ghasemi and Nosratollah Zarghami




Biologics in Inflammatory and Immunomediated Arthritis

, 2017; 18(12): 989 - 1007

Michele M. Luchetti*, Devis Benfaremo and Armando Gabrielli




Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α Inhibitors

, 2017; 18(12): 945 - 963

Anna Campanati, Elisa Molinelli*, Valerio Brisigotti and Annamaria Offidani










Most Cited Articles


Novel Therapeutic Targets for Phosphodiesterase 5 Inhibitors: current state-of-the-art on systemic arterial hypertension and atherosclerosis

, 2016; 17(4): 347-364.

Elisardo C. Vasquez, Agata L. Gava, Jones B. Graceli, Camille M. Balarini, Bianca P. Campagnaro, Thiago de Melo C. Pereira and Silvana S. Meyrelles


DOI: 10.2174/1389201017666151223123904



Harnessing Bioinformatics for Designing a Novel Multiepitope Peptide Vaccine Against Breast Cancer

, 2016; 17(12): 1100-1114.

Shirin Mahmoodi, Navid Nezafat, Abolfazl Barzegar, Manica Negahdaripour, Ali R. Nikanfar, Nosratollah Zarghami and Younes Ghasemi


DOI: 10.2174/1389201017666160914191106






Ovarian Stimulation Protocol in IVF: An Up-to-Date Review of the Literature

, 2016; 17(4): 303-315.

Alessandro Pacchiarotti, Helmy Selman, Claudia Valeri, Simona Napoletano, Marco Sbracia, Gabriele Antonini, Giulio Biagiotti and Arianna Pacchiarotti


DOI: 10.2174/1389201017666160118103147




Most Accessed Articles

CAR T-cell Therapy: A New Era in Cancer Immunotherapy

, 2018; 19(1): 5-18.

Miliotou N. Androulla and Papadopoulou C. Lefkothea*


DOI: 10.2174/1389201019666180418095526



New Developments in Pichia pastoris Expression System, Review and Update

, 2018; 19(6): 451-467.

Roghayyeh Baghban, Safar Farajnia*, Younes Ghasemi, Mojtaba Mortazavi, Nosratollah Zarghami and Naser Samadi


DOI: 10.2174/1389201019666180718093037


HELLP Syndrome: Pathophysiology and Current Therapies

, 2018; 19(10): 816-826.

Kedra Wallace*, Sharonda Harris, Augustina Addison and Cynthia Bean


DOI: 10.2174/1389201019666180712115215



Phage Therapy in Clinical Practice: Treatment of Human Infections

, 2010; 11(1): 69-86.

Elizabeth Kutter, Daniel De Vos, Guram Gvasalia, Zemphira Alavidze, Lasha Gogokhia, Sarah Kuhl and Stephen T. Abedon


DOI: 10.2174/138920110790725401







Webmaster Contact: info@benthamscience.net
Copyright © 2019 Bentham Science | Privacy Policy